Limited data exist describing the use and role of vibrators in a urogynecology population and no randomized controlled trials investigating the use of vibrators as a therapeutic tool to enhance sexual and pelvic floor function in urogynecology patients has been conducted. This study aims to evaluate the efficacy of vibrator use in improving sexual and pelvic floor function in urogynecology patients who report sexual dysfunction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
84
A handout on how to improve sexual dysfunction/function will be provided
An FDA approved vibrator device to improve sexual function will be provided
Albany Medical Center
Albany, New York, United States
RECRUITINGFemale Sexual Function Index
A 19 question validated survey on sexual function with lower scores indicating worse outcome
Time frame: up to 12 weeks
Pelvic Floor Distress Inventory -20
20 question validated survey on pelvic floor dysfunction with lower scores indicating worse outcomes
Time frame: up to 12 weeks
Pelvic Organ Prolapse incontinence sexual questionnaire 12
a 12 question validated survey on sexual function in patients with pelvic floor dysfunction with lower scores indicating worse outcomes
Time frame: up to 12 weeks
sexual satisfaction index
a validated questionnaire on sexual satisfaction with lower scores indicating worse outcomes
Time frame: up to 12 weeks
female genitourinary pain index
validated survey on genitourinary pain in females with lower scores indicating worse outcomes
Time frame: up to 12 weeks
patient health questionnaire 9
validated questionnaire on depression with lower scores indicating worse outcomes
Time frame: up to 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.